[29V03-pm] 構造活性相関①

Mon. Mar 29, 2021 1:15 PM - 2:51 PM [Room V03] Oral Presentation 3 (Online)

座長：渡邉瑞貴（北大院薬）、菅原章公（東北大院薬）

+Add all to schedule

1:15 PM - 1:27 PM

[29V03-pm01] Development of novel selective TGR5 ligands based on 5,6,7,8-tetrahydonaphthalene skeleton

○Takashi Misawa¹, Ryusei Terui^2,1, Yuta Yanase^3,1, Hidetomo Yokoo¹, Makoto Makishima⁴, Yoshitomo Suhara², Yosuke Demizu^1,3 (1. NIHS, 2. Shibaura institute of Technology, 3. Yokohama city university, 4. Nihon Univ. school of medicine)

1:27 PM - 1:39 PM

[29V03-pm02] Structure-activity relationship (SAR) study of farnesoid X receptor (FXR) agonists with N¹-substituted benzimidazole scaffold.

○Arisa Masuda¹, Yusuke Iguchi², Ko Fujimori³, Keigo Gohda⁴, Yukiko Yamashita², Naoki Teno¹ (1. Grad. Sch. Pharm. Sci., Hiroshima International Univ., 2. Fac. Pharm. Sci., Hiroshima International Univ., 3. Dept. Pathobiochem., Osaka Univ. Pharm. Sci., 4. CAMM-Kansai)

1:39 PM - 1:51 PM

[29V03-pm03S] Structure-activity-relationship of fentanyl analogues.

○Hironobu Arita¹, Yuki Kanase², Kosho Makino¹, Hidetsugu Tabata², Tetsuta Oshitari², Hideaki Natsugari³, Hideyo Takahashi¹ (1. Faculty of Pharmaceutical Sciences, Tokyo University of Science., 2. Faculty of Pharma Sciences, Teikyo University., 3. Faculty of Pharmaceutical Sciences, The University of Tokyo.)

1:51 PM - 2:03 PM

[29V03-pm04S] Structure-activity relationship studies of DAG-lactone derivatives for cure of HIV infectious diseases

○Takahiro Ishii¹, Takuya Kobayakawa¹, Kouki Matsuda², Kohei Tsuji¹, Kazuhisa Yoshimura³, Hiroaki Mitsuya^2,4, Kenji Maeda², Hirokazu Tamamura¹ (1. Inst. Biomater. & Bioeng., Tokyo Med. & Dent. Univ., 2. Natl. Ctr. Glob. Health & Med. Res. Inst., 3. Tokyo Metro. Inst. Pub. Health, 4. Natl. Cancer Inst., Natl. Inst. Health)

2:03 PM - 2:15 PM

[29V03-pm05S] Synthetic studies on GPR35 agonist without species-specificity

○Toru Oyama¹, Tomohiro Watanabe¹, Takuto Koide¹, Tomoko Hashimoto¹, Miyako Naganuma¹, Yui Taniguchi¹, Sota Akaki², Kazuyuki Furuta², Satoshi Tanaka³, Osamu Ohno¹, Kenji Matsuno¹ (1. School of Advanced Engineering, Kogakuin University, 2. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 3. Kyoto Pharmaceutical University)

2:15 PM - 2:27 PM

[29V03-pm06S] Synthetic studies on LSD1 inhibitors

Ryo Tabusa¹, ○Ayane Shiobara¹, Shunsuke Fukasawa¹, Tomoko Hashimono¹, Shun Hashimoto¹, Osamu Ohno¹, Hideaki Niwa², Shin Sato², Takashi Umehara², Matsuno Kenji¹ (1. School of Advanced Engineering, Kogakuin University, 2. RIKEN Center for Biosystems Dynamics Research)

2:27 PM - 2:39 PM

[29V03-pm07S] Rational design of amphipathic antimicrobial peptide foldamers

○Motoharu Hirano^1,2, Chihiro Saito³, Chihiro Goto^1,2, Ryuji Kawano³, Takashi Misawa², Yosuke Demizu^2,1 (1. Grad. Sch. Med. Life. Sci., Yokohama city Univ., 2. NIHS, 3. Dept. Biotech. Life Sci., Tokyo Univ. Agr. Tech.)

2:39 PM - 2:51 PM

[29V03-pm08] Development of peptide-based degradation inducer against nuclear receptors

○Takahito Ito¹, Hidetomo Yokoo¹, Nobumichi Ohoka¹, Mikihiko Naito^1,3, Takao Inoue¹, Yosuke Demizu^1,2 (1. NIHS, 2. Grad. Sch. Med Life Sci., Yokohama city Univ., 3. Grad. Sch. Pharm., Tokyo Univ.)

Session information